Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.

Research paper by Francesco F Barchiesi, Elisabetta E Spreghini, Serena S Tomassetti, Daniela D Arzeni, Daniele D Giannini, Giorgio G Scalise

Indexed on: 24 Nov '05Published on: 24 Nov '05Published in: Antimicrobial agents and chemotherapy


We investigated the fungicidal activity of caspofungin (CAS) and amphotericin B (AMB) against 16 clinical isolates of Candida glabrata. The minimum fungicidal concentrations (MFCs) of CAS were similar to those of AMB, ranging from 2.0 to >8.0 microg/ml. Time-kill assays performed on selected isolates showed that AMB was fungicidal at concentrations four times the MIC while CAS was not. A neutropenic-mouse model of disseminated infection was utilized to determine the residual fungal kidney burden. While doses as low as 0.3 and 1 mg/kg of body weight/day of CAS and AMB, respectively, were effective at reducing the counts with respect to controls, organ sterilization was reached when both drugs were administered at 5 mg/kg/day. Our study reveals that, similar to AMB, CAS has the potential for a fungicidal effect in vivo against this difficult-to-treat fungal pathogen.